Key Points
- Insider sale: BillionToOne SVP Bosch John Roderick Ten sold 1,417 shares at $100 each, reducing his holdings by 5.08% to 26,467 shares. The transaction occurred under a pre-arranged Rule 10b5-1 trading plan.
- Stock and earnings: BLLN opened at $95.15, with a $4.49 billion market capitalization and a 12-month range of $61.96 to $150.44. The company matched quarterly earnings expectations at $0.15 per share and reported $109.45 million in revenue.
- Analyst outlook: Analysts maintain a “Moderate Buy” consensus with an average price target of $126.71, although BTIG Research and JPMorgan recently reduced their targets to $130.
Billiontoone, Inc. (NASDAQ:BLLN - Get Free Report) SVP Bosch John Roderick Ten sold 1,417 shares of the company's stock in a transaction dated Tuesday, August 25th. The shares were sold at an average price of $100.00, for a total transaction of $141,700.00. Following the completion of the transaction, the senior vice president owned 26,467 shares in the company, valued at $2,646,700. This trade represents a 5.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Bosch John Roderick Ten also recently made the following trade(s):
- On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $92.86, for a total transaction of $131,582.62.
- On Monday, June 29th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $120.00, for a total transaction of $169,920.00.
- On Monday, June 15th, Bosch John Roderick Ten sold 2,832 shares of Billiontoone stock. The shares were sold at an average price of $101.47, for a total transaction of $287,363.04.
Billiontoone Stock Performance
Shares of NASDAQ:BLLN opened at $95.15 on Friday. Billiontoone, Inc. has a 12-month low of $61.96 and a 12-month high of $150.44. The company's 50 day moving average price is $115.34 and its two-hundred day moving average price is $95.29. The firm has a market cap of $4.49 billion and a PE ratio of 135.93. The company has a quick ratio of 11.31, a current ratio of 11.69 and a debt-to-equity ratio of 0.17.
Billiontoone (NASDAQ:BLLN - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, meeting analysts' consensus estimates of $0.15. The company had revenue of $109.45 million during the quarter. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. Equities research analysts predict that Billiontoone, Inc. will post 0.83 earnings per share for the current year.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the company. Adams Street Partners LLC acquired a new position in Billiontoone during the fourth quarter valued at approximately $140,063,000. Price T Rowe Associates Inc. MD acquired a new stake in shares of Billiontoone in the 4th quarter valued at $39,717,000. JPMorgan Chase & Co. acquired a new stake in shares of Billiontoone in the 4th quarter valued at $32,078,000. Wasatch Advisors LP bought a new position in shares of Billiontoone in the 1st quarter valued at $29,179,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of Billiontoone in the 4th quarter valued at $18,631,000.
Wall Street Analysts Forecast Growth
BLLN has been the subject of several analyst reports. BTIG Research dropped their price objective on Billiontoone from $142.00 to $130.00 and set a "buy" rating for the company in a report on Thursday, August 6th. Wall Street Zen lowered Billiontoone from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Guggenheim started coverage on Billiontoone in a research report on Monday, June 29th. They issued a "buy" rating and a $125.00 price target on the stock. Weiss Ratings raised Billiontoone from a "sell (d)" rating to a "sell (d+)" rating in a research note on Tuesday, June 23rd. Finally, JPMorgan Chase & Co. cut their price objective on shares of Billiontoone from $145.00 to $130.00 and set an "overweight" rating for the company in a research report on Thursday, August 6th. Six research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $126.71.
Read Our Latest Analysis on BLLN
About Billiontoone
(
Get Free Report)
BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.
BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
